secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2024-07-23T23:59:59+00:00
Accession:  0001356576-24-000039
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus announces Q2 2024 earnings date: Aug 6 after market close
------------------------------------------------------------------

- Q2 2024 financial and business results to be reported after market close on Tuesday, August 6, 2024.
- CEO Jack Khattar and CFO Tim Dec will host a conference call at 4:30 p.m. ET on August 6.
- Live webcast available on Supernus investor relations website; replay accessible for 60 days.
- No preliminary financial results or guidance were provided in this announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000039/0001356576-24-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657624000039/supn-20240723.htm
  HTML page:      https://secwatch.observer/filing/0001356576-24-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer